Portfolio

We are enabling companies to turn their boldest ambitions into world-changing breakthroughs in healthcare and technology.

Portfolio

Spotlights Portfolio List

Portfolio List

Regulates stablecoin for efficient global transactions and yield generation.
Offers cost-effective healthcare data interoperability using FHIR standards for improved insights across diverse populations.
Explores Glia's role in brain disease, acquired by Neumora.
Acquired by Neumora
Develops innovative embolotherapy using inorganic polymer microspheres for hypervascular tumors.
Develops nausea treatments for surgical and cancer patients.
Acquired by Eagle Pharmaceuticals / EURONEXT: ACPH
Democratizes flow cytometry for medical research.
Acquired by Becton Dickinson
Develops innovative therapies for unmet needs in dermatology and immunodermatology.
NASDAQ:ACRS
Uses Smart Antibody Technology to accelerate development and reduce costs in antibody discovery.
NASDAQ: ADAG
Develops engineered T-cell therapies (TCR T-cells) to treat solid tumor and hematological cancers.
NASDAQ: ADAP
Develops protein conjugate therapies, combining biologics and small molecule payloads to treat cancer.
Uses genome-wide methylation analysis for earlier, precise cancer and morbidity detection.
Developing a protein nanoparticle (PNP) delivery platform.
Develops transformative gene therapies for devastating diseases using rationally designed AAV vectors.
Was a leading wireless networking company with AireWave Director software; acquired by Cisco in 2005.
Acquired by Cisco
AI-powered R&D platform for chemistry and materials science.
Providing C2C, B2C, and B2B sales services.
NYSE: BABA
Develops targeted radioligand therapies (RLTs) to improve cancer treatment globally.
Develops precision medicines targeting protein synthesis for breakthrough cancer therapies.
Developing Amber-UI neuromodulation therapy using Picostim for urinary incontinence.
Developed minimally invasive medical devices to restore quality of life from Overactive Bladder Syndrome.
Acquired by Hologic
Develops novel therapies by inhibiting the complement system at the C3 level.
NASDAQ: APLS
Mobile advertising measurement platform for real-time user acquisition campaign analysis.
Provides global access to employment data for verification, earnings insights, and worker profiles.
Develops alpha radioligand therapies (ARTs) for targeted cancer treatment with resilient supply chain.
Optimizes benefits programs with actionable data insights.
Acquired by Nomi Health
Developed Ontozry™ (cenobamate) to treat epilepsy.
Acquired by Angelini Pharma
All-in-one recruiting platform for high-growth companies, combining features with advanced analytics.
Developing neurodegenerative disease treatments using proprietary RNA interference platform.
Develops improved therapies for idiopathic pulmonary fibrosis (IPF) and other respiratory diseases.
Tech-enabled hospitality offering consistent quality for group travelers in authentic settings.
Develops CAR-T cell therapies using switchable and scalable platforms for cancers.
Pioneering gene therapy company focused on transformative medicines for neurodegenerative disorders.
Developing innovative neuromodulation technology to treat large disease populations.
Developing innovative neuromodulation technology to treat large disease populations.
Specializes in distributed ledger infrastructure for major financial institutions, workflow automation.
Develops innovative orthopedic solutions to restore patient mobility and enhance surgical outcomes.
Pioneering CRISPR base editing for precision genetic medicines to treat disease.
NASDAQ: BEAM
Modern software and AI tools for bioscientists.
AI-powered discovery for disease biology.
Develops and commercializes novel digital programmable hearing aid solutions for China.
Develops biologics combining targeted therapy with tumor modulators to enhance immune activity.
NASDAQ:BCAX
Focuses on developing therapies for diseases of the eye.
Acquired by Shire
Developed a CE-Marked product for improving dialysis access surgery.
Developing base editing technology for a range of applications.
Develops and commercializes high-quality hyaluronic acid (HA) based products for the Chinese market.
Secures and manages open source software worldwide.
Acquired by Synopsys
Precision therapy company striving to improve human health.
Acquired by Sanofi / NASDAQ: BPMC
Online symptom and cure checker that uses an intelligent algorithm backed by medical data to diagnose patients.
Develops fully autonomous farming robots to automate tasks and enhance workforce efficiency.
Develops therapies for epilepsy and other neurological disorders with neural implant technology.
Modernizes hotel operations with its mobile web Guest Management System globally.
Unlocks private markets through automation for institutional investors.
Rapidly growing pharmaceutical company focusing on emerging markets and expanding into regulated markets.
Developed lixivaptan for hyponatremia treatment.
Acquired by Cornerstone Therapeutics
Cloud-based platform combining dental practice management, patient engagement, and data analytics.
Pioneering CRISPR genome editing for new medical therapies.
NASDAQ: CRBU
Global fertility benefits provider offering customizable support for employees' family-building journeys.
Transforming warehouse operations through robotic automation.
Zero-configuration solution for account takeover (ATO) protection.
Employs DragonFold technology for rapid protein/ligand co-folding to develop novel drugs.
Immune-activating cancer therapy company acquired by Regeneron in 2022, developed vidutolimod.
Acquired by Regeneron / NASDAQ: CMPI
Develops and commercializes consumer healthcare and over-the-counter products.
Scalable NoSQL Database-as-a-Service for modern applications
Acquired by IBM
Cloud-based CI/CD testing platform.
Acquired by Cloudbees
Develops antibody-coupled T-cell receptor platform to target and kill tumor cells.
NASDAQ:COGT
Develops and commercializes high-quality biosimilar therapeutics worldwide using advanced analytics.
Developing the first therapy targeting a root cause of preterm preeclampsia to reduce risks for mothers and babies, including premature birth.
Develops antibodies targeting tumor-immune synapse for comprehensive cancer treatment.
NASDAQ: CMPX
Revolutionizes payment distribution with combined merchant acquiring and virtual card issuing solution.
Provides high-end diagnostics for disease stratification and therapy selection.
Acquired by Metropolis Healthcare
Redefining PCR with single-molecule precision and category-defining sensitivity.
Leader in discovery and development of novel drugs in stem cell related diseases.
Seed-stage venture firm and accelerator for therapeutics startups, providing expertise and capital.
Provides compact, affordable flow cytometry instruments with high multiplexing capabilities.
NASDAQ: CTBK
Global, comprehensive POI datasets.
AI to automate traditionally manual processes in travel.
Developing therapies for neurodegenerative diseases through rigorous research.
NASDAQ: DNLI
AAV gene therapy developer for rare diseases.
Acquired by Ultragenyx Pharmaceuticals
Client data management platform enabling advisors to collect, structure, and sync data across the advisor tech stack.
Developing innovative therapies for neurological and psychiatric disorders.
Developing curative medicines through precision in vivo cellular engineering.
Specializing in biosimilars and novel biologics for global healthcare markets.
Offers interest rate hedging and options on interest rates and cryptocurrencies.
Acquired by CME
Developing cell and gene therapy manufacturing solutions for life sciences companies.
Connecting financial institutions with consumers with API and an embedded finance marketplace.
Acquired by MoneyLion
Developing innovative treatments for eye diseases and vision disorders.
SHA: 688050
Focused on affordable, high-quality medicines for patients worldwide.
Developing pulsed field ablation technology for cardiac arrhythmia treatment.
Acquired by Boston Scientific
Specializing in global payment solutions for complex, high-value transactions for various industries.
NASDAQ: FLWY
Developing small molecule therapeutics for protein misfolding and aggregation diseases.
Acquired by Pfizer
Automating collection, storage, and analysis of advertising data.
Offers automated investment management and financial planning services to individuals.
Acquired by BlackRock
Improving diagnostic testing and accelerate drug discovery in diverse underserved populations.
Leveraging genomics data science to improve drug R&D and for population health.
Offering geospatial network data for infrastructure planning and analysis.
Acquired by Cisco Systems
Embedded insurance with digital-first approach and user-friendly platform.
Leading animal vaccine manufacturer in China.
603718.SS
Offers live, expert-led classes for managers and emerging leaders through a professional development platform.
Hemostatic product manufacturer in China.
Developing innovative drugs for diabetes and related metabolic disorders.
2552.KHK
Leading provider of enterprise contract management software using AI to optimize business processes.
Omnichannel point-of-sale (PoS) softare for retailers.
Developing Midazolam Nasal Spray (USL261) for acute repetitive seizures.
Acquired by UCB
Leading the change in cell & gene therapies & personalized immunotherapy.
Dedicated to developing novel treatments for fibrotic diseases.
Developing and commercializing high-quality biologic medicines.
1801.HK
Harnessing deep learning to accelerate pharmaceutical development.
Developing therapies for serious and rare diseases, including respiratory and inflammatory conditions.
NASDAQ: INSM
Developing novel protein-based therapeutics for companion animals.
Acquired by Dechra
Developing and commercializing innovative medicines focused on gastrointestinal diseases.
NASDAQ: IRWD
Eliminating infusion-related patient harm.
Acquired by Fresenius Kabi
Developing novel treatments for unmet medical needs.
Targets epigenetic pathways to develop innovative cancer therapies.
Providing insights for financial services and government sectors through AI-powered analytics.
Acquired by S&P Global
Provides patient access and provider data management solutions.
Developing innovative therapies for autoimmune and inflammatory diseases.
NASDAQ: LSB
Offers maintenance coordination and resident amenity services thrrough property management technology.
Engineering microbes to produce animal-free proteins and growth factors for biopharma, food, health, and personal care markets.
Research-driven pharmaceutical manufacturing organization.
NSE: LAURUSLABS
Simplifies lead management and sales prospecting.
Develops and produces insulin pumps.
Developing nasal spray products to prevent respiratory viruses.
Provides of web-based private benefits exchanges to small and medium-sized businesses.
Acquired by Towers Watson
Leading commercial platform for the travel & hospitality industry.
Developing innovative vaccines for the prevention of gastrointestinal diseases.
Acquired by Takeda
Provides visibility and collaboration tools for logistics companies though digital freight forwarding.
Manufactures, develops, and commercializes high quality, affordably priced cardiovascular and general surgery medical devices.
Developing antibody-drug conjugates for cancer treatment.
NASDAQ: MRSN
Bringing cell-based therapies to heart failure patients.
Developing next-generation medicines for obesity and metabolic diseases.
NASDAQ: MTSR
Offering cloud, data center, and managed IT solutions.
Acquired by Roche Company
Automates accounts payable and payment for mid-market businesses.
Acquired by Global Payments
Develops targeted therapies for rare genetic diseases and mitochondrial disorders.
Acquired by Zogenix
Uses AI-powered insights for personalized marketing campaigns to drive customer engagement.
Offers digital banking services for children and families.
Acquired by Sokin
Building human-embodied intelligence to empower humans.
Manufactures and markets minimally invasive interventional therapy medical devices in the field of ENT, cardiovascular and others.
Revolutionizing in vivo targeted genetic medicines with best-in-class cargo and precision delivery.
Providing whole genome sequencing and analysis services through personal genomics.
Acquired by ProPhase Labs
Building intelligent applications and machine learning solutions.
Developing precision medicines for brain diseases.
NASDAQ: NMRA
Creates and promotes differentiated products in the pediatric market.
Acquired by Pfizer
Develops targeted therapies for fibrotic diseases and other dermatological conditions.
Developing novel therapeutics for neurogenic cough and inflammation.
Developing small molecule inhibitors of the NLRP3 inflammasome.
Provides cryptocurrency compliance for virtual asset service providers and financial institutions.
Automating and digitizing physician workflows though AI-powered healthcare
Develops innovative therapies to address unmet medical needs in various diseases.
Acquired by SciClone
Providing speech recognition and natural language processing solutions through conversational AI technology.
NASDAQ: NUAN
Provides cybersecurity and data leakage prevention systems.
Acquired by Raytheon
Offers backup, recovery, and compliance solutions for Salesforce through enterprise data protection.
Accelerating the advancement of globally competitive oncology assets for patients.
Developing sustainable, electric self-driving systems for urban mobility.
Acquired by Magna
Developing treatments for rare diseases using bone-marrow gene therapy.
NASDAQ: ORTX
Promotes the development of cervical cancer screening and prevention in China.
Providing private speech therapy clinics in China.
Enables collaboration for secure file sharing, data privacy, and remote access.
Acquired by Kiteworks
Offers clean-label wellness supplements for health-conscious consumers through plant-based nutrition.
Simplifying bill payments with secure, user-friendly mobile solutions.
Vertical software and embedded fintech for LatAm restaurants.
Developing and introducing effective and clinically proven children's medicines for China.
Designing novel therapeutics against previously undruggable targets using experimental and computational biophysics.
Automated visual testing for web and mobile interfaces.
Acquired by BrowserStack
Offers medicine delivery, diagnostic tests, and teleconsultations through online healthcare.
Provides secure, seamless authentication and access management solutions.
Acquired by Vista Equity Partners
Developing and supplying plasma protein therapies for the treatment of rare and chronic diseases.
Revolutionizing the future of transportation by building the safest and most reliable self-driving technology.
NASDAQ: PONY
Engineering advanced therapies for genetic and oncological diseases through genome editing.
NASDAQ: DTIL
Pioneering gene-editing solutions using precision genome engineering technologies.
NASDAQ: PRME
Developing therapies for neuropsychiatric and neurodevelopmental disorders.
Connecting borrowers and investors for affordable financial solutions.
Protect patient data and prevent privacy breaches through healthcare compliance.
Acquired by Bluesight
Developing therapies targeting protein misfolding diseases.
Merged with Yumanity Therapeutics in 2020
Developing inhaled therapies for severe respiratory infections and lung conditions.
Developing hardware and software solutions for advanced computing.
Empowering financial institutions with insights for wealth management solutions through data aggregation.
Acquired by Plaid
Empowering financial institutions with insights for wealth management solutions through data aggregation.
NASDAQ: RLYB
Developing precision diagnostic solutions for cell analysis and research.
Developing and commercializing therapies for rare diseases in Asia.
Platform for managing API documentation and developer hubs.
Subscription management and billing platform for recurring revenue businesses
Acquired by Accel-KKR
Providing quality medical equipment and supporting healthcare professionals and patients.
Advancing AAV-based treatments for rare genetic diseases through gene therapy.
NASDAQ: RGNX
Developing innovative inhaled therapies for severe respiratory diseases.
Acquired by Centocor Ortho Biotech
Developing gene therapies for retinal diseases causing blindness.
Builds intelligent, automated picking solutions for warehouse fulfillment.
Developing RNA-based therapeutics for immune modulation and viral defense.
Risklens is a cyber risk analytics platform helping businesses quantify and manage financial risk.
Acquired by Safe Security
Assesses third-party vendor risks through automated security analysis.
Acquired by Mastercard
Evaluation, testing, and simulation platform for voice agents.
Discovering and developing novel first-in-class small molecule drugs with the potential to address multiple psychiatric indications.
Developing cell and gene therapies for complex diseases.
NASDAQ: SANA
Leveraging machine learning for threat detection and response.
Acquired by Vista Equity Partners
Offering streamlined financial services for underserved communities.
Developing cell therapies for treating type 1 diabetes.
Acquired by Vertex
A leading global provider of image grade LiDAR technology, enabling autonomy for intelligent transportation, robotics and industrial automation.
Developing therapies that target aging at the cellular level.
Pioneering novel immunotherapies for cancer treatment.
Facilitating data-driven life science research and empowering drug R&D processes.
Revolutionizing global shipping with transparent pricing, real-time tracking, and eco-friendly solutions.
Enables personalized marketing campaigns through data unification.
Developing advanced DNA sequencing solutions though genomics technology.
NASDAQ: OMIC
Developing treatments for age-related degenerative diseases.
Developing innovative treatments for genetic diseases through gene therapy.
Streamlines real estate document management and closing processes.
Providing AI-driven claims management solutions for insurance carriers.
Helping independent workers find personalized health insurance plans.
Developing oral therapies for chronic metabolic and cardiovascular diseases.
NASDAQ: GPCR
Developing next-generation antibody therapies focused on the tumor microenvironment.
NASDAQ:SURF
Developing innovative treatments for women’s health conditions.
Advancing TCR bispecific therapies for cancer and autoimmune disorders.
Transforming global drug discovery with advanced AI and physics-based technologies.
Provides diagnostic equipment designed to offer services and support in the field of obstetrics and gynecology and pathology
Acquired by Hologic
Retrofitting construction and mining equipment for supervised autonomy.
Develops small molecule therapeutics designed to effectively treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity.
NASDAQ: TPST
Developing a novel therapy to treat presbyopia.
Improving the lives of patients and caregivers impacted by neurological, cardiometabolic, and ophthalmic diseases.
Developing antibiotics for multi-drug-resistant infections.
NASDAQ: TTPH
Providing real-time threat detection and risk management though cloud security.
Acquired by F5 Networks
The leading POS and SaaS platform for restaurants.
NYSE: TOST
Financial Operating System for Latin American Enterprises.
Developing treatments for pediatric infectious diseases.
Acquired by Sanofi
Offers data, trading, and analytics solutions for digital assets.
Acquired by CoinDesk
Provides APIs for active trading and brokerage solutions.
Developing inhaled therapies for respiratory and lung infections.
Acquired by Insmed Inc.
Offers customized itineraries, booking tools, and trip management solutions.
Developing diagnostic and imaging solutions for healthcare providers.
Developing cancer therapies that activate T-cell responses through immuno-oncology.
NASDAQ: TSBX
Developing innovative treatments for rare and ultra-rare diseases.
NASDAQ: RARE
Enhances product discovery with personalized search and recommendations through AI-driven e-commerce.
Acquired by Netcore Cloud
Offers equity-sharing solutions to home buyers and owners.
Developing specialized psychiatric hospitals for underserved communities.
Helps businesses buy and manage software efficiently.
Ensures secure digital transactions through biometric authentication.
Acquired by EMC
Developing treatments for cardiovascular diseases though gene-editing.
NASDAQ: VERV
Assists businesses in offering modern 401(k) and savings plans.
Developing treatments for dermatological conditions like rosacea.
Acquired by Allergan
Developing MRI-guided radiation therapy systems for cancer treatment.
NASDAQ: VRAY
Developing treatments for immuno-inflammatory conditions.
NASDAQ: VYNE
Enables personalized networking and relationship-building for professionals.
Helps users navigate software through interactive guidance and support.
Developing AI-driven therapies for complex diseases.
Engineering tumor-activated therapies for targeted cancer treatment.
NASDAQ: XLO
Enables fast, secure money transfers across global markets.
Acquired by PayPal
Developing minimally invasive treatments for benign prostatic hyperplasia.
The companies identified do not represent all the companies purchased, sold, or recommended for portfolios advised by F-Prime.